Ken Vroman
At a glance: Ken Vroman is Chief Transformation Officer at CME Group (CME). Their latest SEC Form 4, filed Mar 12, 2026, reported a sale of $1.6M. On file: 0 purchase lines ($0) and 1 sale line ($1.6M).
Disclosed holdings: about $4.6M of CME stock: 14,910 shares reported on their latest Form 4 (filed Mar 12, 2026), valued at the Nov 20, 2026 close of $311.15. This counts only CME shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Chief Transformation Officer at Cme Group Inc. (CME)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 12SEC | CMECme Group Inc. | Sell | 5,16014,910 held (−26%) | $309.00 | $1.6M | +0.7% |
- Sell
Chief Transformation Officer Ken Vroman sold $1.6M of CME at $309.00 — cuts the stake by 26%.
Follow Ken Vroman
Get one email when Ken Vroman files a new purchase or sale. Free.
At most one email a day about Ken Vroman, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.